The Know ALL website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know ALL cannot guarantee the accuracy of translated content. Know ALL and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
How does access to healthcare affect the patient journey with ALL?
Yervand Hakobyan
July 29, 2024
Know ALL was pleased to speak to Yervand Hakobyan, Armenian Hematology Association, Armenia. We asked, "How does access to healthcare affect the patient journey with ALL?"
Hakobyan begins by discussing how access to healthcare can be a multi-level problem for patients, starting with appointment availability and office hours. In some countries, hematology centres may be very far from smaller cities and villages, which can make regular appointments difficult.
Then, he explains how access to therapies and diagnostics can vary between countries, which can lead to delays in treatment. Stem cell transplant can be very difficult to access in some countries, with the high cost limiting access to this treatment for many patients. Hakobyan also discusses the difficulties in accessing clinical trials.
